ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00898950
Recruitment Status : Completed
First Posted : May 12, 2009
Last Update Posted : May 12, 2009
Sponsor:
Information provided by:
University of Portsmouth

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2006
  Actual Study Completion Date : July 2006